Shifting the cancer paradigm: must we kill to cure?

J Clin Oncol. 1995 Apr;13(4):801-7. doi: 10.1200/JCO.1995.13.4.801.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Female
  • Humans
  • Male
  • Neoplasms / drug therapy*
  • Neoplasms / mortality
  • Neoplasms / pathology
  • Remission Induction
  • Survival Rate

Substances

  • Antineoplastic Agents